<?xml version="1.0" encoding="UTF-8"?><!--This XML data has been generated under the supervision of the European Patent Office --><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.7.1//EN" "ep-patent-document-v1-7-1.dtd">
<ep-patent-document country="EP" date-publ="20261007" doc-number="4815980" dtd-version="ep-patent-document-v1-7-1" file="24817200.9" id="EP24817200A1" kind="A1" lang="en" status="n"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMDGE........</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>0009010-RPUB02</B007EP></eptags></B000><B100><B110>4815980</B110><B130>A1</B130><B140><date>20261007</date></B140><B190>EP</B190></B100><B200><B210>24817200.9</B210><B220><date>20241127</date></B220><B240><B241><date>20260609</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>202363603418 P</B310><B320><date>20231128</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20261007</date><bnum>202641</bnum></B405><B430><date>20261007</date><bnum>202641</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  39/00        20060101AFI20250606BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61P  35/00        20060101ALI20250606BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C07K  16/30        20060101ALI20250606BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C07K  16/28        20060101ALI20250606BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61P  35/04        20060101ALI20250606BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>C07K  16/2803      20130101 FI20250206BHEP        </text></classification-cpc><classification-cpc sequence="2"><text>C07K2317/31        20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="3"><text>C07K  16/28        20130101 LI20250206BHEP        </text></classification-cpc><classification-cpc sequence="4"><text>C07K  16/30        20130101 LI20250206BHEP        </text></classification-cpc><classification-cpc sequence="5"><text>A61K2039/505       20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="6"><text>C07K2317/33        20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="7"><text>C07K2317/90        20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="8"><text>C07K2317/94        20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="9"><text>A61K2039/54        20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="10"><text>A61K2039/545       20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="11"><text>A61P  35/00        20180101 LI20250206BHEP        </text></classification-cpc><classification-cpc sequence="12"><text>A61P  35/04        20180101 LI20250206BHEP        </text></classification-cpc><classification-cpc sequence="13"><text>C07K  16/2818      20130101 LI20250206BHEP        </text></classification-cpc><classification-cpc sequence="14"><text>A61K2039/507       20130101 LA20250206BHEP        </text></classification-cpc><classification-cpc sequence="15"><text>C07K2317/76        20130101 LA20250206BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>VERFAHREN ZUR BEHANDLUNG VON KRANKHEITEN MIT ANTI-CD47X-ANTI-MESOTHELIN-ANTIKÖRPERN ALS EINZIGES MITTEL UND IN KOMBINATION MIT ANTI-PD-1-ANTIKÖRPERN</B542><B541>en</B541><B542>METHOD OF TREATING DISEASE USING ANTI-CD47 X ANTI-MESOTHELIN ANTIBODIES AS A SOLE AGENT AND IN COMBINATION WITH ANTI-PD-1 ANTIBODIES</B542><B541>fr</B541><B542>PROCÉDÉ DE TRAITEMENT D'UNE MALADIE À L'AIDE D'ANTICORPS ANTI-CD47 ET ANTI-MÉSOTHÉLINE EN TANT QU'AGENT UNIQUE ET EN COMBINAISON AVEC DES ANTICORPS ANTI-PD-1</B542></B540></B500><B700><B710><B711><snm>Novimmune S.A.</snm><iid>102015306</iid><irf>P153219EPPC/ILF</irf><adr><str>Chemin du Pré-Fleuri 15</str><city>1228 Plan-les-Ouates,  Geneva</city><ctry>CH</ctry></adr></B711></B710><B720><B721><snm>SARO SUAREZ, Jose Maria</snm><adr><city>1228 Geneva</city><ctry>CH</ctry></adr></B721><B721><snm>FERLIN, Walter G.</snm><adr><city>1228 Geneva</city><ctry>CH</ctry></adr></B721></B720><B740><B741><snm>Haseltine Lake Kempner LLP</snm><iid>101867295</iid><adr><str>Cheapside House
138 Cheapside</str><city>London EC2V 6BJ</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>ME</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>BA</ctry></B845EP></B844EP><B848EP><B849EP><ctry>GE</ctry></B849EP><B849EP><ctry>KH</ctry></B849EP><B849EP><ctry>MA</ctry></B849EP><B849EP><ctry>MD</ctry></B849EP><B849EP><ctry>TN</ctry></B849EP></B848EP><B860><B861><dnum><anum>EP2024083760</anum></dnum><date>20241127</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2025114357</pnum></dnum><date>20250605</date><bnum>202523</bnum></B871></B870></B800></SDOBI></ep-patent-document>